Page 1
Two modes of exocytosis from synaptosomes are differentially
regulated by protein phosphatase types 2A and 2B
Monique L. Baldwin, John A. P. Rostas and Alistair T. R. Sim
School of Biomedical Sciences, University of Newcastle and Clinical Neuroscience Program, Hunter Medical Research Institute,
Callaghan, New South Wales, Australia
Abstract
The inhibitors okadaic acid (OA), fostriecin (FOS) and
cyclosporin A (CsA), were used to investigate the roles of
protein phosphatases in regulating exocytosis in rat brain
synaptosomes by measuring glutamate release and the
release of the styryl dye FM 2-10. Depolarization was induced
by 30 mM KCl, or 0.3 mM or 1 mM 4-aminopyridine (4AP). OA
and FOS produced a similar partial inhibition of KCl- and
0.3 mM 4AP- evoked exocytosis in both assays, but had little
effect upon exocytosis evoked by 1 mM 4AP. In contrast, CsA
had no effect upon KCl- and 0.3 mM 4AP-evoked exocytosis,
but significantly enhanced glutamate release but not FM 2-10
dye release evoked by 1 mM 4AP. None of the phosphatase
inhibitors changed calcium signals from FURA-2-loaded syn-
aptosomes either before or after depolarization. Pretreatment
with 100 nM phorbol 12-myristate 13-acetate abolished the
inhibitory effect of OA on exocytosis induced by 0.3 mM 4AP.
Taken together, these results show that exocytosis from
synaptosomes has a phosphatase-sensitive and phospha-
tase-insensitive component, and that there are two modes of
phosphatase-sensitive exocytosis that can be elicited by dif-
ferent depolarization conditions. Moreover, these two modes
are differentially sensitive to phosphatase 2A and 2B.
Keywords: exocytosis, FM 2-10, glutamate, kiss-and-run,
protein phosphatase, synaptic vesicle.
J. Neurochem. (2003) 85, 1190–1199.
The modulation of synaptic vesicle cycling is one of the
critical cellular mechanisms that controls synaptic transmis-
sion, regulating the supply of releasable transmitter at the
nerve terminal. Once synaptic vesicles have fused with the
plasma membrane to release neurotransmitters (exocytosis),
they must be recycled so that they can be refilled and
undergo the next round of release. Full synaptic vesicle
fusion, whereby vesicles collapse completely into the plasma
membrane, internalize by endocytosis and then recycle
through the endosome (Alvarez et al. 1993; Ales et al.
1999), is the classical model of exocytosis and the principal
mechanism under normal stimulation conditions (De Camilli
and Takei 1996). However, an alternative mechanism has
been suggested whereby vesicles fuse only transiently with
the plasma membrane and are rapidly retrieved (Valtorta
et al. 2001). In this mode of release, referred to as ‘transient
fusion’ or ‘kiss-and-run’, vesicles fuse with the plasma
membrane by forming a transient fusion pore while preser-
ving vesicle integrity. After detachment, intact vesicles can
fuse again with the plasma membrane without any preceding
endosomal fusion. Kiss-and-run has been demonstrated by
analysis of secretion from neuroendocrine and chromaffin
cells by combining whole-cell capacitance methods and
amperometry to measure vesicle fusion and catecholamine
release of vesicle contents (Alvarez et al. 1993; Zhou et al.
1996). The advantage of a kiss-and-run mechanism is a rapid
cycling between a fusion state and a non-fusion state, thus
accelerating the turnover of the limited pool of synaptic
vesicles in neurons (Cousin and Robinson 1999).
Studies using the lipophilic, but membrane impermeable,
fluorescent styryl dyes in combination with the measurement
of soluble neurotransmitter release have made possible the
investigation of kiss-and-run in neurons (Henkel and Betz
1995; Klingauf et al. 1998). When the styryl dye FM 2-10
reversibly partitions into the outer leaflet of exposed plasma
Received December 15, 2002; revised manuscript received January 23,
2003; accepted February 9, 2003.
Address correspondence and reprint requests to Associate Professor A.
T. R. Sim, School of Biomedical Sciences, University of Newcastle and
Clinical Neuroscience Program, Hunter Medical Research Institute,
Callaghan, NSW 2308, Australia.
E-mail: [email protected]
Abbreviations used: 4AP, 4-aminopyridine; CsA, cyclosporin A; FOS,
fostriecin; OA, okadaic acid; PKC, protein kinase C; PMA, phorbol
12-myristate 13-acetate; PP1, protein phosphatase 1; PP2A, protein
phosphatase 2A; PP2B, protein phosphatase 2B.
Journal of Neurochemistry, 2003, 85, 1190–1199 doi:10.1046/j.1471-4159.2003.01779.x
1190 � 2003 International Society for Neurochemistry, J. Neurochem. (2003) 85, 1190–1199
Page 2
membrane its fluorescence increases. By endocytosis, the dye
is able to label the luminal surface of the synaptic vesicle
and, during subsequent exocytosis, is lost to the extracellular
medium, accompanied by a decrease in fluorescence (Cousin
and Robinson 1999). Release of neurotransmitter is detect-
able whether the nerve terminal uses full fusion or kiss-and-
run, as neurotransmitter is soluble within the synaptic vesicle
and can diffuse rapidly through an open pore. However, only
the relatively slow process of full fusion would allow
complete dye loss from the membrane, whereas in the
relatively rapid kiss-and-run mode the synaptic vesicles are
internalized before the dye can fully departition and escape
from the membrane (Klingauf et al. 1998).
By comparing the relative ability of the glutamate release
and styryl dye release assays to measure exocytosis, Cousin
and Robinson (2000) were able to distinguish between two
different modes of glutamate release from isolated nerve
terminals (synaptosomes); 30 mM KCl and 0.3 mM 4-ami-
nopyridine (4AP) evoked exocytosis by a mechanism that
was readily detectable with both the glutamate and FM 2-10
release assays, and was therefore assumed to be occurring
with the full fusion mode of release. However, 1 mM 4AP
recruited a second mode of release that was detectable using
the glutamate assay but not the FM 2-10 assay; this was
proposed to be kiss-and-run. This second mode was
proposed to be largely mediated by protein kinase C (PKC)
(Cousin and Robinson 2000).
Phosphorylation and dephosphorylation of nerve terminal
proteins is known to regulate neurotransmitter release, and
experiments using membrane-permeable inhibitors of protein
phosphatases suggest that serine/threonine protein phospha-
tases are positive regulators of this release (Sim et al. 1991;
Verhage et al. 1995; Vickroy et al. 1995; Issa et al. 1999;
Storchak et al. 2001). However, the relative importance of
the different serine/threonine protein phosphatases in the full
fusion and kiss-and-run modes of release is not known. The
three major serine/threonine phosphatases are protein phos-
phatase 1 (PP1), 2A (PP2A) and 2B (PP2B), all three of
which are found in rat brain synaptosomes (Sim et al. 1993).
Okadaic acid (OA), an inhibitor of protein phosphatases PP1,
PP2A and to a lesser extent PP2B (Haystead et al. 1989;
Ishihara et al. 1989), inhibits depolarization-induced glu-
tamate release from isolated nerve terminals (synaptosomes)
(Verhage et al. 1995; Vickroy et al. 1995; Issa et al. 1999).
However, it is impossible to ascertain which class of protein
phosphatase is being affected in this attenuation of transmit-
ter release, as OA causes partial or complete inhibition of
several protein phosphatases. The use of selective inhibitors
is necessary to resolve this issue.
We have used the highly selective, membrane-permeable
protein phosphatase inhibitors fostriecin (FOS) and cyclosp-
orin A (CsA) to delineate the class of protein phosphatases
likely to be involved in the release of neurotransmitter from
synaptosomes. Synaptosomes have been used extensively to
study the mechanisms of synaptic neurotransmitter release
because they remain metabolically active and preserve the
ability to synthesize and release neurotransmitters. Our
results support the argument for the presence of two modes
of exocytosis in synaptosomes and, more importantly, show
that PP2A and PP2B have distinct roles in regulating
exocytosis from synaptosomes by these two modes.
Experimental procedures
Materials
OAwas obtained from Alexis Biochemicals (San Diego, CA, USA);
FOS and CsA were obtained from Calbiochem (San Diego, CA,
USA). FM 2-10 and FURA-2 AM were from Molecular Probes
(Eugene, OR, USA). All other reagents were obtained from the
Sigma Chemical Co. (St Louis, MO, USA).
Glutamate release assay
Synaptosomes were prepared from rat brain cerebral cortex by
centrifugation on discontinuous Percoll gradients (fractions 3 and 4
were combined) as described previously (Dunkley et al. 1986).
Under the conditions used, synaptosomes remain viable for several
hours and respond to multiple depolarization and repolarization
signals (Dunkley et al. 1986). The glutamate release assay was
performed using enzyme-linked fluorescent detection of released
glutamate (Nicholls and Sihra 1986). In brief, synaptosomes were
stored on ice and were diluted to 500 lg protein in 2 mL Krebs-like
solution (118 mM NaCl, 5 mM KCl, 25 mM NaHCO3, 1 mM MgCl2,
10 mM Glucose, pH 7.4) at 37�C. Experiments were started after
addition of 1 mM NADP+. Fifty units of glutamate dehydrogenase
were added after 1 min, and the synaptosome suspension was treated
after 4 min with either KCl (30 mM) or 4AP (0.3 or 1 mM).
Fluorescence at 460 nm emission was measured continuously in a
Perkin-Elmer (Shelton, CT, USA) LS-50B spectrofluorimeter using a
four-cuvette holder that enabled four samples to be run simulta-
neously. A typical experiment consisted of two control conditions,
and two treated conditions, each in the presence and absence of Ca2+
(1.2 mM), thus enabling each sample to be measured against its own
control simultaneously. Glutamate release was quantitated by the
addition of 10 nmol glutamate at the end of each run, which acted as
an internal standard that allowed comparison to be made between
experiments. Data are presented as the Ca2+-dependent glutamate
release (expressed in nmoles per milligram protein), measured at
different time points after stimulation (100, 200, 300 and 400 s), and
calculated as the difference between release measured in the presence
and absence of added Ca2+. In experiments in which inhibitors were
used, the synaptosomes were preincubated with either OA (0.01–
10 lM), FOS (0.1 or 1 lM), CsA (10 lM) or phorbol 12-myristate13-acetate (PMA) (100 nM), for 5, 5, 15 or 7 min respectively, before
depolarization with either KCl or 4AP.
None of the drugs used altered basal release (in the presence or
absence of added Ca2+), and none had any effect on either KCl- or
4AP-evoked Ca2+-independent release (data not shown).
Styryl dye release assay
Synaptic vesicle fusion with the plasma membrane was measured
using release of the fluorescent dye FM 2-10, according to Cousin
Protein phosphatase 2A and 2B in exocytosis 1191
� 2003 International Society for Neurochemistry, J. Neurochem. (2003) 85, 1190–1199
Page 3
and Robinson (2000). In brief, synaptosomes were stored on ice and
were diluted to 700 lg protein in 2 mL Ca2+-containing Krebs-like
solution (as used in the glutamate release assay) at 37�C. FM 2-10
(100 lM) was added after 3 min, and endocytotic uptake of
membrane-bound FM 2-10 was stimulated 1 min later with
30 mM KCl. After 2 min to allow internalization of the dye,
synaptosomes were pelleted in a microfuge for 1 min and washed
twice in Krebs-like solution containing 1 mg/mL bovine serum
albumin. Synaptosomes were then resuspended in Krebs-like
solution (either plus or minus 1.2 mM Ca2+) at 37�C, and release
induced by the addition of either KCl (30 mM) or 4AP (0.3 or
1 mM). Release of accumulated FM 2-10 was measured as the
decrease in fluorescence upon release of the dye into solution
(excitation 488 nm, emission 540 nm). Data are presented as the
Ca2+-dependent decrease in FM 2-10 fluorescence and calculated as
the difference between release measured in the presence of 1.2 mM
Ca2+ and that in the presence of 1.2 mM EGTA. Any drugs were
added after the dye-loading procedure, and the synaptosomes were
preincubated with OA (0.01–10 lM), FOS (0.1 lM), CsA (10 lM) orPMA (100 nM) for 5 min before depolarization with either KCl or
4AP. For experiments with PMA and OA, PMAwas added first, and
OA was added 30 s later.
Calcium measurements
Intrasynaptosomal calcium levels were measured using FURA-2
fluorescence according to Brent et al. (1997). FURA-2 was prepared
as a 1-mM stock solution in dimethyl sulfoxide and 0.5% pluronic
acid. In brief, synaptosomes (2 mg protein) were incubated with
gentle shaking for 40 min at 37�C in 2 mL control buffer containing
5 lM FURA-2. The suspensions were then washed in ice-cold
Krebs-like buffer and centrifuged for 2 min to remove extrasyna-
ptosomal FURA-2. Synaptosomes were then stored on ice and
diluted to 600 lg protein in 2 mL Ca2+-containing Krebs-like
solution at 37�C, adjusted to give a final concentration of 1.2 mM
Ca2+ in the cuvette. Measurements were made by alternating the
excitation wavelengths of 340 and 380 nm (the 340 : 380 nm
fluorescence ratio); fluorescent emission was monitored at 510 nm.
Calibration of the fluorescence signals was performed at the end of
each experiment by adding digitonin (200 lM) to obtain Fmaxfollowed by EGTA (2 mM) to obtain Fmin (Grynkiewicz et al.
1985). Extrasynaptosomal FURA-2 was determined for each
synaptosomal preparation by adding MnCl2 (10 mM) at the end of
each experiment to quench the extracellular fluorescence and was
stable for the duration of the experiments. Intracellular [Ca2+] was
calculated by the equation of Grynkiewicz et al. (1985), using a KD
of 81 nM for the Ca2+–FURA-2 complex derived under our
laboratory conditions by scanning the fluorescent response of
FURA-2 to different concentrations of Ca2+ (0–39.8 lM). In
experiments in which drugs were used, the synaptosomes were
preincubated with OA (0.1 lM), FOS (0.1 lM) or CsA (10 lM), for5, 5 or 15 min respectively, before depolarization with either KCl or
4AP. As basal calcium levels in synaptosomes gradually increased
during the 3–4 h involved in a series of experiments (86–117 nM
Ca2+), the sequence of application of drugs was varied between
experiments, and drug-treated samples were compared with control
samples measured immediately before or after the drug-treated
samples. There was no difference in drug effects associated with the
age of the synaptosomes.
Results
Experimental approach
Exocytosis from isolated synaptosomes was measured using
two complementary approaches. Results from the measure-
ment of glutamate and FM 2-10 release in response to three
different stimuli are shown in Fig. 1. Although the time
course of exocytosis is different for the two assays, this is a
reflection of the nature of the assays used rather than an
inherent difference in the mechanisms of exocytosis of
glutamate and FM 2-10. Specifically, the exocytosis of
glutamate is slower than that of FM 2-10 as a consequence
of the dilution of released glutamate into a large volume of
buffer. This results in submaximal conditions for the
glutamate dehydrogenase used in the assay. The signal
generated over minutes by the assay therefore represents
enzymatic amplification of the glutamate released within
seconds. FM dye is released more slowly than glutamate
owing to the requirement for it to departition from the
membrane before a signal is generated. However, it is
measured directly, producing a signal in seconds, and
therefore has a shorter time course than measurement of
glutamate.
Measurement of glutamate release clearly restricts the
measurement of exocytosis to glutamatergic synaptosomes,
although these do represent a large proportion of the
synaptosomes in the preparation. Measurement of FM 2-10
dye release, on the other hand, is independent of the
neurotransmitter, and represents exocytosis from all syna-
ptosomes. In order to restrict analysis to exocytosis rather
than signals generated by non-specific leaching or bleaching
of the dye, results are reported as only the Ca2+-dependent
release.
Two alternate modes of depolarization were studied (KCl
and 4AP) to investigate whether any effects of the phospha-
tase inhibitors on glutamate release were due to actions on
events associated with exocytosis, as opposed to the
depolarization-activated steps that trigger exocytosis. KCl
produces a clamped depolarization, whereas 4AP, at the
Fig. 1 Ca2+-dependent glutamate (a) and FM 2-10 (b) release evoked
by 30 mM KCl, 0.3 mM 4AP and 1 mM 4AP. Arrowhead shows when
depolarizing agents were added. Each point is the mean ± SEM of
3–4 independent experiments.
1192 M. L. Baldwin et al.
� 2003 International Society for Neurochemistry, J. Neurochem. (2003) 85, 1190–1199
Page 4
concentrations used, leads to propagation of repetitive action
potentials by blocking both A type and delayed rectifier
potassium channels, thereby preventing correction of spon-
taneous depolarizations that occur from ion diffusion (Nich-
olls 1993). Levels of Ca2+-dependent glutamate release
evoked by 30 mM KCl and 0.3 mM 4AP were similar,
whereas depolarization with 1 mM 4AP evoked more release
(Fig. 1a). However, the depolarization-stimulated FM 2-10
release was similar for all depolarizing stimuli (Fig. 1b).
These results are consistent with the findings of Cousin and
Robinson (2000) that the slow rate of diffusion of FM 2-10
dye limits its capacity to detect short-duration modes of
exocytosis, suggesting that the increased exocytosis promo-
ted by higher 4AP concentrations represents a ‘kiss-and-run’-
like mode.
Regression analysis of FM 2-10 release indicated that the
data were consistent with two phases of release. The biphasic
nature of exocytosis from synaptosomes has been well
documented although the interpretation of this remains
unclear. Analysis showed that the initial rate constant for
each of the three depolarization conditions was similar
(s ¼ 4–6 s). Importantly, these kinetics of FM dye release
derived from a population of synaptosomes are within the
same order of magnitude as that observed in a single
presynaptic bouton from an intact neuron (Ryan et al. 1993).
Effects of OA and FOS: role of PP1 and PP2A
in exocytosis
The protein phosphatase inhibitor OA has previously been
shown to inhibit KCl-evoked glutamate release in synapto-
somes (Verhage et al. 1995). In this study OA inhibited this
release by a mean ± SEM of 58 ± 5% at 100 s (Fig. 2a).
Investigation of the concentration dependence of this inhi-
bition of glutamate release showed that inhibition was
maximal at 0.1 lM; increasing the OA concentration 100-
fold to 10 lM did not significantly change this inhibition
(data not shown). This also suggests that PP2B, which is
inhibited by OA at 10 lM but not at 0.1 lM (Cohen 1989),
has little role in regulating release under these conditions.
However, it cannot be determined whether the major
inhibitory effect on release seen at lower OA concentrations
results from inhibition of PP2A and/or PP1. FOS (0.1 lM), apotent and selective inhibitor of PP2A (Evans and Simon
2001), inhibited glutamate release to a similar extent as OA
(Fig. 2b). Increasing the concentration of FOS to 1 lM did
not change the extent of inhibition (data not shown). There
was no significant difference (p > 0.24, Student t-test)
between the level of inhibition of Ca2+-dependent release
by OA and FOS at any time after depolarization. The effect
of OA and FOS on glutamate release evoked by 0.3 mM 4AP
(Figs 2c and d) followed the same pattern as that observed
following KCl-evoked release; OA (0.1 lM) and FOS
(0.1 lM) inhibited Ca2+-dependent release to a similar extent.These results suggest a major role for PP2A in the regulation
of KCl- and 0.3 mM 4AP-evoked glutamate release. In
contrast, the effect of phosphatase inhibition on release
evoked by 1 mM 4AP was markedly different: OA and FOS
(Figs 2e and f respectively) had little or no effect on Ca2+-
dependent glutamate release.
To investigate whether the effects of OA and FOS were
specific for glutamate release or more generally applicable to
the mechanisms of synaptic exocytosis, we next investigated
FM 2-10 release and compared the results with the profile of
glutamate release under the same conditions. The effects of
the phosphatase inhibitors OA and FOS on depolarization-
stimulated FM 2-10 release are shown in Fig. 3. OA and
FOS both inhibited FM 2-10 release in the same manner as
that observed for glutamate release. Inhibition was greatest
when release was evoked by KCl or 0.3 mM 4AP (Figs 3a–d):
31 ± 4 and 28 ± 2% inhibition of KCl-evoked release, and
30 ± 3 and 31 ± 3% inhibition of 0.3 mM 4AP-evoked
release respectively (3 min after depolarization). Kinetic
analysis showed that the rate constants (s) of release were not
Fig. 2 Effect of OA and FOS on Ca2+-dependent release of glutamate
in synaptosomes depolarized by 30 mM KCl (a and b), 0.3 mM 4AP (c
and d), and 1 mM 4AP (e and f). Synaptosomes were preincubated
with either 0.1 lM OA (a, c and e; dotted line) or 0.1 lM FOS (b, d and
f; dashed line) before depolarization. Each point is the mean ± SEM of
3–4 independent experiments.
Protein phosphatase 2A and 2B in exocytosis 1193
� 2003 International Society for Neurochemistry, J. Neurochem. (2003) 85, 1190–1199
Page 5
affected by the inhibitors (not shown); rather, as indicated by
the figures, the effect was on the extent of the first phase. In
contrast to release measured in response to 30 mM KCl or
0.3 mM 4AP, neither OA nor FOS significantly affected
release evoked by 1 mM 4AP (Figs 3e and f).
It has been shown that PMA greatly increases glutamate
release stimulated by 0.3 mM 4AP, but not FM 2-10 release;
this has been interpreted as resulting from a switch from full
fusion to kiss-and-run release (Cousin and Robinson 2000).
Although PMA has a number of targets, this effect of PMA is
assumed to be related to activation of PKC as it is blocked by
inhibition of PKC (Cousin and Robinson 2000). Consistent
with these results, we found that PMA increased 0.3 mM
4AP-evoked Ca2+-dependent glutamate release by 103 ± 8%
but had no effect on FM 2-10 release (Fig. 4). In addition,
OA (0.1 lM) produced no change in 0.3 mM 4AP-evoked
release in the presence of PMA for both assays, whereas it
reduced 0.3 mM 4AP-evoked release of glutamate and
FM 2-10 by 64 ± 7% and 30 ± 3% respectively in the
absence of PMA (Fig. 2c and Fig. 3c respectively). Taken
together, these results are consistent with the hypothesis
that PMA induces a switch from full fusion to kiss-and-run as
the predominant mode of release (Cousin and Robinson
2000).
Effects of CsA: role of PP2B in exocytosis
To further investigate the role of different phosphatases in
exocytosis we investigated the effect of the PP2B-selective
inhibitor CsA (Liu et al. 1991) on both glutamate and FM2-
10 release. Using this inhibitor, we observed no significant
change in Ca2+-dependent glutamate release following
KCl- or 0.3 mM 4AP-induced depolarization (Figs 5a and b
respectively). This is consistent with our findings that 10 lMOA (which also inhibits PP2B) had no greater effect on
glutamate release than 0.1 lM OA, suggesting that PP2B
plays little role in regulating the release of glutamate evoked
by KCl or 0.3 mM 4AP. In contrast, CsA significantly
increased glutamate release evoked by 1 mM 4AP, and the
degree of stimulation increased with time reaching 59 ± 6%
above control values by 400 s (Fig. 5c).
CsA did not affect FM 2-10 release under any of the
depolarization conditions used (Fig. 6). The lack of effect on
KCl- and 0.3 mM 4AP-stimulated release correlates well with
results for glutamate release. However, CsA greatly increased
Ca2+-dependent glutamate release stimulated with 1 mM
4AP, whereas FM 2-10 release was virtually unaffected.
This is consistent with CsA affecting a second mode of
exocytosis that is less apparent in the FM 2-10 assay.
Fig. 3 Effect of OA and FOS on Ca2+-dependent release of FM 2-10 in
synaptosomes depolarized by 30 mM KCl (a and b), 0.3 mM 4AP (c and
d), and 1 mM 4AP (e and f). Arrowhead shows when depolarizing agent
was added. Synaptosomes were preincubated with either 0.1 lM OA
(a, c and e) or 0.1 lM FOS (b, d and f) before depolarization. C, control.
Each point is the mean ± SEM of 3–4 independent experiments.
Fig. 4 Effect of OA on 0.3 mM 4AP-evoked glutamate release (a) and
FM 2-10 release (b) in the presence of PMA. Arrowhead shows when
depolarizing agent was added. Each point is the mean ± SEM of 3–4
independent experiments.
1194 M. L. Baldwin et al.
� 2003 International Society for Neurochemistry, J. Neurochem. (2003) 85, 1190–1199
Page 6
Effects of phosphatase inhibition on calcium levels
To test the possibility that the effects of protein phosphatase
inhibition on exocytosis were via modulation of calcium
influx, mean calcium levels were measured using the
fluorescent dye, FURA-2. Figure 7 shows that, under the
conditions used, none of the inhibitors changed synapto-
somal calcium levels under basal conditions or after depo-
larization with either KCl or 4AP (0.3 mM and 1 mM). The
increase in levels of calcium induced by depolarization with
1 mM 4AP, the stimulus that induces the kiss-and-run-like
mode of exocytosis, was significantly greater than that
induced by depolarization with 0.3 mM 4AP, the stimulus
that primarily induces the full fusion mode of exocytosis
(p < 0.0001, Student’s t-test). There was no significant
difference between the calcium levels induced by depolar-
ization with 0.3 mM 4AP or KCl, both of which induce
exocytosis by full fusion.
Discussion
Isolated synaptosomes provide a useful model with which to
study synaptic exocytosis. Although the measurement of
exocytosis and endocytosis in all in vitro preparations does
not fully match the millisecond timescale that occurs in vivo,
the molecular machinery underlying exocytosis is the same
and all in vitro approaches, including electrophysiological
ones, take advantage of artificially reduced rates to probe
these molecular mechanisms. Interestingly, the rate constant
of diffusion of FM dye in the present study, which measures
a population of nerve terminals, is similar to that seen by
direct imaging of individual hippocampal neurons (Ryan
et al. 1993).
The inhibition of KCl-evoked release by OA has been
observed in several cell types (Verhage et al. 1995; Vickroy
et al. 1995; Issa et al. 1999), but no previous release studies
Fig. 5 Effect of selective inhibition of PP2B on Ca2+-dependent
release of glutamate in synaptosomes depolarized by 30 mM KCl (a),
0.3 mM 4AP (b) and 1 mM 4AP (c). Synaptosomes were preincubated
with 10 lM CsA (dotted line) before depolarization. Each point is the
mean ± SEM of 3–4 independent experiments.
Fig. 6 Effect of selective inhibition of PP2B on Ca2+-dependent
release of FM 2-10 in synaptosomes depolarized by 30 mM KCl (a),
0.3 mM 4AP (b) and 1 mM 4AP (c). Arrowhead shows when depolar-
izing agent was added. Synaptosomes were preincubated with 10 lM
CsA before depolarization. C, control. Each point is the mean ± SEM
of 3–4 independent experiments.
Protein phosphatase 2A and 2B in exocytosis 1195
� 2003 International Society for Neurochemistry, J. Neurochem. (2003) 85, 1190–1199
Page 7
have examined the effects of specifically inhibiting PP2A.
We have now been able to do this using FOS, a PP2A
inhibitor that is 10 000-fold more selective for PP2A than for
PP1 (Walsh et al. 1997). Our finding that FOS inhibited KCl-
and 0.3 mM 4AP-evoked glutamate release to a similar extent
as OA shows that the principal phosphatase regulating
release under these conditions is PP2A, although a role for
PP1 cannot be ruled out. The results with FM 2-10
strengthen this interpretation, depicting a similar pattern of
effect of OA and FOS on release evoked by KCl and 0.3 mM
4AP. The lack of effect of PP2B inhibition using the specific
inhibitor CsA (Liu et al. 1991) confirmed that PP2B plays
little role in release under these conditions. In view of the
well recognized role of PP2B in endocytosis (Liu et al.
1994), one might have expected to see some effect of PP2B
inhibition on the release of glutamate. The fact that PP2B
inhibition had no observable effect on release indicates that
glutamate release measurements under these experimental
conditions primarily reflect steps in the synaptic vesicle
fusion cycle associated with recruitment of release-ready
vesicles and fusion with the membrane, rather than the whole
synaptic vesicle cycle. It is important to note that maximal
inhibition of PP2A evoked by KCl- and 0.3 mM 4AP evoked
release does not completely inhibit release. Therefore,
exocytosis from synaptosomes has both phosphatase-sensi-
tive and phosphatase-insensitive components.
Cousin and Robinson (2000) reported no increase in
FM 2-10 release as the concentration of 4AP was increased
from 0.3 to 1 mM, despite an increase in glutamate release
under the same conditions. Our results follow the same
pattern and are therefore consistent with the interpretation
that a different mechanism of release is recruited at higher
concentrations of 4AP. Our results with phosphatase inhib-
itors reveal that under these different depolarization condi-
tions exocytosis also shows a differential pharmacological
sensitivity. This further strengthens the hypothesis that
different mechanisms of release occur under different
depolarization conditions. Specifically, OA and FOS inhib-
ited exocytosis evoked by KCl and 0.3 mM 4AP, but not that
evoked by 1 mM 4AP, whereas CsA increased glutamate
release evoked by 1 mM 4AP but had no effect on release
evoked by 0.3 mM 4AP and KCl.
The release of glutamate is detectable whether the nerve
terminal uses the full fusion or kiss-and-run-like mode of
exocytosis because glutamate is soluble within the synaptic
vesicle and able to diffuse rapidly into the extracellular
space, even if the vesicle remains fused for only a short
period (as happens during kiss-and-run). However, the loss
of FM 2-10 styryl dye from the luminal surface of the vesicle
membrane is slow, so that only the relatively long duration of
full fusion would allow substantial dye loss from the
membrane. In the relatively short duration of the kiss-and-
run mode of exocytosis the synaptic vesicles are internalized
before most of the dye can escape from the membrane.
It is therefore proposed that the mode of release seen at
high concentrations of 4AP represents a kiss-and-run-type
Fig. 7 Effect of protein phosphatase inhib-
itors on calcium levels in synaptosomes
depolarized with 30 mM KCl (a, b and c),
0.3 mM 4AP (d, e and f) or 1 mM 4AP (g, h
and i). Each panel contains average traces
for 3–5 experiments normalized to a com-
mon starting calcium level. Control (filled
circle) and drug treatment (open square)
traces are both plotted but are virtually co-
incident. Addition of drug and depolarizing
agent are indicated by the downward and
upward arrowheads respectively.
1196 M. L. Baldwin et al.
� 2003 International Society for Neurochemistry, J. Neurochem. (2003) 85, 1190–1199
Page 8
mechanism because it is observed with the glutamate release
assay but not with the FM 2-10 release assay. Furthermore,
we propose that PP2A is a positive regulator of the full
fusion mode of exocytosis, shown by the ability of PP2A
inhibitors (OA and FOS) to inhibit both glutamate and
FM 2-10 release stimulated by KCl or 0.3 mM 4AP. However,
PP2A appears to have little role to play in the kiss-and-run-
like mode of exocytosis, as indicated by the lack of effect of
OA and FOS on glutamate and FM 2-10 release evoked by
1 mM 4AP. The differential ability of the two measures of
exocytosis to detect the effects of PP2B inhibition on 1 mM
4AP-evoked release suggests that PP2B is involved in
regulating the kiss-and-run-like mode of exocytosis, in
addition to its known role in endocytosis (Liu et al. 1994).
The differential effect of PP2B inhibition on glutamate
release induced by 30 mM KCl and 1 mM 4AP was first
noted by Nichols et al. (1994) but, in that study, the
difference was assumed to be due to differences in the mode
of depolarization. Our results show that this is not the case:
changing the mode of depolarization does not change the
sensitivity to the phosphatase inhibitors, as long as the same
mechanism of release is activated. Using two different
depolarization stimuli, KCl and 0.3 mM 4AP, each of which
induces full fusion release, no sensitivity to the PP2B
inhibitor CsA was observed. However, sensitivity to the
PP2B inhibitor was seen when the same depolarizing agent
(4AP) was used at a higher concentration (1 mM) because a
different mode of exocytosis that is sensitive to PP2B action
was induced.
Valtorta et al. (2001) discussed the possibility of both
modes of release operating in synapses, with a switch to kiss-
and-run occurring as vesicles acquire the ‘competence’ to
release neurotransmitter in this way. By using amperometry,
Ales et al. (1999) showed that, in response to an increase in
extracellular Ca2+, chromaffin cells shifted from the full
fusion mode to the kiss-and-run mechanism. During kiss-
and-run events the fusion pore appeared to expand briefly to
a large size, allowing for rapid and complete transmitter
release. There was no size difference between vesicles that
underwent full fusion and those that released transmitter by
the kiss-and-run mechanism. This shows that vesicle cycling
can be consistent with both full fusion and transient fusion.
The rise in intracellular Ca2+ can be induced by increasing
the concentration of Ca2+ in the incubation medium or by
applying robust electrical stimulation paradigms (von Gers-
dorff and Matthews 1994; Ales et al. 1999; Pyle et al. 2000;
Beutner et al. 2001), but also after the application of phorbol
esters (Cousin and Robinson 2000). Phorbol esters, which
activate PKC, increase the release of neurotransmitter in
many neuronal systems (Malenka et al. 1986; Gerber et al.
1989; Barrie et al. 1991; Coffey et al. 1993; Capogna et al.
1995, 1999; Stevens and Sullivan 1998; Chen et al. 1999;
Cousin and Robinson 1999; Yawo 1999), including syna-
ptosomes. Although PMA has a number of targets, the
enhancement of exocytosis is blocked by inhibitors of PKC
(Cousin and Robinson 2000). Activation of PKC in chrom-
affin cells accelerated fusion pore expansion and subsequent
pore closure and vesicle retrieval (Graham et al. 2000).
Is the additional mode of exocytosis induced in synapto-
somes at high 4AP in addition to full fusion, or does the
predominant mode of release switch from one mode to
another? Our studies with phosphatase inhibitors add support
to the latter conclusion. As FOS or OA inhibited release
evoked by 0.3 mM but had no effect on release evoked by
1 mM 4AP, the simplest interpretation is that, by increasing
the concentration of 4AP, a switch has occurred in the
phosphatase-sensitive component of release from full fusion
to the kiss-and-run-like mode. Cousin and Robinson (2000)
reported that PMA induced a switch in the predominant
mode of release from full fusion to kiss-and-run when
synaptosomes were stimulated by 0.3 mM 4AP. We have
confirmed these results and now show that, in the presence of
PMA, OA produced no change in 0.3 mM 4AP-evoked
release; however, in the absence of PMA, OA inhibited
0.3 mM 4AP-evoked release. These results are further
evidence for the interpretation that a switch occurs in the
predominant mode of release under these conditions, at least
for the phosphatase-sensitive component of release.
One potential implication of a switch in the predominant
mode of exocytosis is that release evoked by 0.3 mM 4AP
plus PMA might be increased by PP2B inhibition with CsA
(as seen for 1 mM 4AP). However, for this to be true, the
CsA-sensitive step must be rate limiting even in the presence
of PMA. We found that CsA had no effect on synaptosomes
pretreated with 100 nM PMA (maximal stimulation of
glutamate release) and depolarized with 0.3 mM 4AP (results
not shown). Attempts to repeat the experiment with
submaximal concentrations of PMA were unsuccessful
because of the extremely steep dose–response curve of
PMA (50 nM had no discernible effect on glutamate release).
At which point in the synaptic vesicle cycle are the serine/
threonine phosphatases acting to differentially regulate the
two modes of release? These enzymes are likely to have
many substrate proteins involved in many aspects of the
synaptic vesicle cycle such that no single protein is likely to
be the target. One possibility is that the protein phosphatase
inhibitors modulate exocytosis through modulation of cal-
cium levels. However, experiments using FURA-2 did not
show an effect of any phosphatase inhibitor on calcium levels
under basal or stimulated conditions (Fig. 7). This suggests
that the major role for PP2A and PP2B in regulating
exocytosis is downstream of calcium influx, but their targets
remain unknown. Interestingly, CsA also increased exocyto-
sis from synaptosomes induced by ionomycin (Jovanovic
et al. 2001), which is consistent with a role for PP2B
downstream of calcium entry. Our studies also suggest that
the mode of exocytosis induced by ionomycin is also of the
kiss-and-run type.
Protein phosphatase 2A and 2B in exocytosis 1197
� 2003 International Society for Neurochemistry, J. Neurochem. (2003) 85, 1190–1199
Page 9
Although the molecular mechanisms underlying the two
modes of exocytosis have not been delineated, the emerging
concept is that the two modes involve the same molecular
components (Valtorta et al. 2001). Thus after a vesicle has
fused with the membrane, it reaches a point in the common
pathway when it must decide whether to proceed via the full
fusion or the kiss-and-run mode; this decision is made by
regulatory molecular mechanisms that alter the rates of the
two pathways in response to different stimulatory conditions.
This is interesting in view of recent mathematical modeling
which suggests that the predominant role of protein
phosphatases in the control of intracellular processes is to
regulate the rate and duration of signaling (Heinrich et al.
2002). The simplest interpretation of our results is that PP2A
promotes the step(s) that commit the vesicle to full fusion
and, under normal depolarization conditions, the mechanism
for retrieval of the vesicle by the kiss-and-run-like mode is
not activated. Upon stimulation with a high 4AP concentra-
tion, the alternative pathway for the retrieval of the vesicle by
the kiss-and-run-like mode is activated and the retrieval of
vesicles is held in check by PP2B activity. Alternatively,
PP2A and/or PP2B might be influencing the delivery of
synaptic vesicles to the readily releasable pool or the plasma
membrane. This is consistent with the recent finding that in
response to 1 mM 4AP there is a rapid dephosphorylation of
PP2B-specific sites on synapsin I, a protein involved in
synaptic vesicle trafficking from reserve pools (Jovanovic
et al. 2001). Given that PP2A influences only full fusion and
PP2B influences only the kiss-and-run-like mode of exocy-
tosis, this interpretation of our data would, however, imply
that each mode uses different molecular machinery for the
delivery of synaptic vesicles to the plasma membrane.
We have focused on the phosphatase-sensitive component
of exocytosis and argued that increasing stimulation induces
a switch in the predominant mode of exocytosis. This leaves
open the question as to whether a similar switch occurs in the
phosphatase-insensitive component. Chromaffin cells can
show an increase in kiss-and-run from 20 to 80% of the
release mechanism under conditions of high stimulation
(Ales et al. 1999). As we do not know how many kiss-and-
run cycles occur during a typical assay or what proportion of
the vesicular styryl dye is released during a single fusion
event, we cannot determine the relative proportions of full
fusion and kiss-and-run involved in the phosphatase-insen-
sitive modes of release from synaptosomes using these
techniques. The mechanisms responsible for the switch
between the modes of release, and the identity of the protein
phosphatase-sensitive control points, remain to be deter-
mined.
Acknowledgements
This research was supported by grants from the National Health
Medical Research Council of Australia, a University of Newcastle
postgraduate scholarship to MLB, and infrastructure funding from
NSW Department of Health through the Hunter Medical Research
Institute. We are grateful to Dr Derek Laver for assistance with
linear regression analysis of FM 2-10 release and we also thank
Professor Peter Dunkley and Dr Martı́n Cammarota for helpful
discussions.
References
Ales E., Tabares L., Poyato J. M., Valero V., Lindau M. and Alvarez d. T.
(1999) High calcium concentrations shift the mode of exocytosis to
the kiss-and-run mechanism. Nat. Cell Biol. 1, 40–44.
Alvarez d. T., Fernandez-Chacon R. and Fernandez J. M. (1993) Release
of secretory products during transient vesicle fusion. Nature 363,
554–558.
Barrie A. P., Nicholls D. G., Sanchez-Prieto J. and Sihra T. S. (1991) An
ion channel locus for the protein kinase C potentiation of trans-
mitter glutamate release from guinea pig cerebrocortical synapto-
somes. J. Neurochem. 57, 1398–1404.
Beutner D., Voets T., Neher E. and Moser T. (2001) Calcium dependence
of exocytosis and endocytosis at the cochlear inner hair cell
afferent synapse. Neuron 29, 681–690.
Brent P. J., Herd L., Saunders H., Sim A. T. and Dunkley P. R. (1997)
Protein phosphorylation and calcium uptake into rat forebrain
synaptosomes: modulation by the sigma ligand, 1,3-ditolylguani-
dine. J. Neurochem. 68, 2201–2211.
Capogna M., Gahwiler B. H. and Thompson S. M. (1995) Presynaptic
enhancement of inhibitory synaptic transmission by protein kinases
A and C in the rat hippocampus in vitro. J. Neurosci. 15, 1249–
1260.
Capogna M., Fankhauser C., Gagliardini V., Gahwiler B. H. and
Thompson S. M. (1999) Excitatory synaptic transmission and its
modulation by PKC is unchanged in the hippocampus of GAP-43-
deficient mice. Eur. J. Neurosci. 11, 433–440.
Chen Y. A., Duvvuri V., Schulman H. and Scheller R. H. (1999) Cal-
modulin and protein kinase C increase Ca2+-stimulated secretion
by modulating membrane-attached exocytic machinery. J. Biol.
Chem. 274, 26469–26476.
Coffey E. T., Sihra T. S. and Nicholls D. G. (1993) Protein kinase C and
the regulation of glutamate exocytosis from cerebrocortical syna-
ptosomes. J. Biol. Chem. 268, 21060–21065.
Cohen P. (1989) The structure and regulation of protein phosphatases.
Annu. Rev. Biochem. 58, 453–508.
Cousin M. A. and Robinson P. J. (1999) Mechanisms of synaptic vesicle
recycling illuminated by fluorescent dyes. J. Neurochem. 73,
2227–2239.
Cousin M. A. and Robinson P. J. (2000) Two mechanisms of synaptic
vesicle recycling in rat brain nerve terminals. J. Neurochem. 75,
1645–1653.
De Camilli P. and Takei K. (1996) Molecular mechanisms in synaptic
vesicle endocytosis and recycling. Neuron 16, 481–486.
Dunkley P. R., Jarvie P. E., Heath J. W., Kidd G. J. and Rostas J. A.
(1986) A rapid method for isolation of synaptosomes on Percoll
gradients. Brain Res. 372, 115–129.
Evans D. R. and Simon J. A. (2001) The predicted beta12–beta13 loop is
important for inhibition of PP2Acalpha by the antitumor drug
fostriecin. FEBS Lett. 498, 110–115.
Gerber G., Kangrga I., Ryu P. D., Larew J. S. and Randic M. (1989)
Multiple effects of phorbol esters in the rat spinal dorsal horn.
J. Neurosci. 9, 3606–3617.
von Gersdorff H. and Matthews G. (1994) Dynamics of synaptic vesicle
fusion and membrane retrieval in synaptic terminals. Nature 367,
735–739.
1198 M. L. Baldwin et al.
� 2003 International Society for Neurochemistry, J. Neurochem. (2003) 85, 1190–1199
Page 10
Graham M. E., Fisher R. J. and Burgoyne R. D. (2000) Measurement of
exocytosis by amperometry in adrenal chromaffin cells: effects of
clostridial neurotoxins and activation of protein kinase C on fusion
pore kinetics. Biochimie 82, 469–479.
Grynkiewicz G., Poenie M. and Tsien R. Y. (1985) A new generation of
Ca2+ indicators with greatly improved fluorescence properties.
J. Biol. Chem. 260, 3440–3450.
Haystead T. A., Sim A. T., Carling D., Honnor R. C., Tsukitani Y.,
Cohen P. and Hardie D. G. (1989) Effects of the tumour promoter
okadaic acid on intracellular protein phosphorylation and meta-
bolism. Nature 337, 78–81.
Heinrich R., Neel B. G. and Rapoport T. A. (2002) Mathematical models
of protein kinase signal transduction. Mol. Cell. 9, 957–970.
Henkel A. W. and Betz W. J. (1995) Staurosporine blocks evoked release
of FM1-43 but not acetylcholine from frog motor nerve terminals.
J. Neurosci. 15, 8246–8258.
Ishihara H., Martin B. L., Brautigan D. L., Karaki H., Ozaki H., Kato Y.,
Fusetani N., Watabe S., Hashimoto K. and Uemura D. (1989)
Calyculin A and okadaic acid: inhibitors of protein phosphatase
activity. Biochem. Biophys. Res. Commun. 159, 871–877.
Issa A. M., Gauthier S. and Collier B. (1999) Effects of calyculin A and
okadaic acid on acetylcholine release and subcellular distribution
in rat hippocampal formation. J. Neurochem. 72, 166–173.
Jovanovic J. N., Sihra T. S., Nairn A. C., Hemmings H. C. Jr, Greengard
P. and Czernik A. J. (2001) Opposing changes in phosphorylation
of specific sites in synapsin I during Ca2+-dependent glutamate
release in isolated nerve terminals. J. Neurosci. 21, 7944–7953.
Klingauf J., Kavalali E. T. and Tsien R. W. (1998) Kinetics and regu-
lation of fast endocytosis at hippocampal synapses. Nature 394,
581–585.
Liu J., Farmer J. D., Lane W. S., Friedman J., Weissman I. and Schreiber
S. L. (1991) Calcineurin is a common target of cyclophilin–
cyclosporin A and FKBP–FK506 complexes. Cell 66, 807–815.
Liu J. P., Sim A. T. and Robinson P. J. (1994) Calcineurin inhibition of
dynamin I GTPase activity coupled to nerve terminal depolariza-
tion. Science 265, 970–973.
Malenka R. C., Madison D. V. and Nicoll R. A. (1986) Potentiation
of synaptic transmission in the hippocampus by phorbol esters.
Nature 321, 175–177.
Nicholls D. G. (1993) The glutamatergic nerve terminal. Eur. J. Bio-
chem. 212, 613–631.
Nicholls D. G. and Sihra T. S. (1986) Synaptosomes possess an exo-
cytotic pool of glutamate. Nature 321, 772–773.
Nichols R. A., Suplick G. R. and Brown J. M. (1994) Calcineurin-me-
diated protein dephosphorylation in brain nerve terminals regulates
the release of glutamate. J. Biol. Chem. 269, 23817–23823.
Pyle J. L., Kavalali E. T., Piedras-Renteria E. S. and Tsien R. W. (2000)
Rapid reuse of readily releasable pool vesicles at hippocampal
synapses. Neuron 28, 221–231.
Ryan T. A., Reuter H., Wendland B., Schweizer F. E., Tsien R. W. and
Smith S. J. (1993) The kinetics of synaptic vesicle recycling
measured at single presynaptic boutons. Neuron 11, 713–724.
Sim A. T., Dunkley P. R., Jarvie P. E. and Rostas J. A. (1991) Modu-
lation of synaptosomal protein phosphorylation/dephosphorylation
by calcium is antagonised by inhibition of protein phosphatases
with okadaic acid. Neurosci. Lett. 126, 203–206.
Sim A. T., Lloyd H. G., Jarvie P. E., Morrison M., Rostas J. A. and
Dunkley P. R. (1993) Synaptosomal amino acid release: effect of
inhibiting protein phosphatases with okadaic acid. Neurosci. Lett.
160, 181–184.
Stevens C. F. and Sullivan J. M. (1998) Regulation of the readily
releasable vesicle pool by protein kinase C. Neuron 21, 885–893.
Storchak L. G., Kravchuk M. V. and Himmelreich N. H. (2001) Okadaic
acid and cyclosporin A modulate [3H]GABA release from rat brain
synaptosomes. Neurochem. Int. 38, 445–451.
Valtorta F., Meldolesi J. and Fesce R. (2001) Synaptic vesicles: is kissing
a matter of competence? Trends Cell Biol. 11, 324–328.
Verhage M., Hens J. J., De Grann P. N., Boomsma F., Wiegant V. M.,
da Silva F. H., Gispen W. H. and Ghijsen W. E. (1995) Ba2+
replaces Ca2+/calmodulin in the activation of protein phosphatases
and in exocytosis of all major transmitters. Eur. J. Pharmacol. 291,
387–398.
Vickroy T. W., Malphurs W. L. and Carriger M. L. (1995) Regulation of
stimulus-dependent hippocampal acetylcholine release by okadaic
acid-sensitive phosphoprotein phosphatases. Neurosci. Lett. 191,
200–204.
Walsh A. H., Cheng A. and Honkanen R. E. (1997) Fostriecin, an
antitumor antibiotic with inhibitory activity against serine/threon-
ine protein phosphatases types 1 (PP1) and 2A (PP2A), is highly
selective for PP2A. FEBS Lett. 416, 230–234.
Yawo H. (1999) Protein kinase C potentiates transmitter release from the
chick ciliary presynaptic terminal by increasing the exocytotic
fusion probability. J. Physiol. 515, 169–180.
Zhou Z., Misler S. and Chow R. H. (1996) Rapid fluctuations in
transmitter release from single vesicles in bovine adrenal chrom-
affin cells. Biophys. J. 70, 1543–1552.
Protein phosphatase 2A and 2B in exocytosis 1199
� 2003 International Society for Neurochemistry, J. Neurochem. (2003) 85, 1190–1199